青霉胺治疗硬皮病性心脏病
Treatment of scleroderma heart by D-penicillamine.
作者信息
Muers M, Stokes W
出版信息
Br Heart J. 1976 Aug;38(8):864-7. doi: 10.1136/hrt.38.8.864.
Abstract
A case of severe diffuse systemic sclerosis with cardiomegaly and cardiac failure is described. Treatment with D-penicillamine caused a pronounced decrease in heart size, together with clinical improvement. The use of penicillamine in scleroderma heart has not previously been reported.
摘要
本文描述了一例患有心脏肥大和心力衰竭的严重弥漫性系统性硬化症病例。使用青霉胺治疗后，心脏大小显著减小，同时临床症状有所改善。此前尚未有关于在硬皮病性心脏病中使用青霉胺的报道。
相似文献
1
Treatment of scleroderma heart by D-penicillamine.青霉胺治疗硬皮病性心脏病
Br Heart J. 1976 Aug;38(8):864-7. doi: 10.1136/hrt.38.8.864.
2
Nodular scleroderma in systemic sclerosis under D-penicillamine therapy.青霉胺治疗下系统性硬化症中的结节性硬皮病
J Dermatol. 1992 Dec;19(12):968-71. doi: 10.1111/j.1346-8138.1992.tb03814.x.
3
Penicillamine in systemic sclerosis: a reappraisal.青霉胺治疗系统性硬化症：重新评估
Clin Rheumatol. 1990 Dec;9(4):517-22. doi: 10.1007/BF02030514.
4
D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
J Rheumatol. 1983 Apr;10(2):316-8.
5
Progressive systemic sclerosis and penicillamine.
J Rheumatol Suppl. 1981 Jan-Feb;7:116-20.
6
(D)-penicillamine treatment in systemic sclerosis (scleroderma). Effect on nutritional capillary circulation.（D）-青霉胺治疗系统性硬化症（硬皮病）。对营养性毛细血管循环的影响。
Scand J Rheumatol. 1977;6(2):92-6. doi: 10.3109/03009747709095427.
7
D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma).青霉胺治疗系统性硬化症（硬皮病）患者的肺部受累情况。
Arthritis Rheum. 1987 Jul;30(7):832-4. doi: 10.1002/art.1780300716.
8
D-penicillamine in systemic sclerosis? Yes!
Scand J Rheumatol. 2001;30(4):192-4. doi: 10.1080/030097401316909503.
9
D-penicillamine treatment in systemic sclerosis.青霉胺治疗系统性硬化症。
J Rheumatol. 1991 Oct;18(10):1435-7.
10
[D-penicillamine in the treatment of progressive systemic sclerosis].
AMB Rev Assoc Med Bras. 1980 Jun;26(6):191-3.
Zotero 插件